| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486353 | Vaccine | 2017 | 9 Pages |
Abstract
The safety profile of ZVL, following 10â¯years of post-marketing use, was favorable and consistent with that observed in clinical trials and post-licensure studies.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
English D. Willis, Meredith Woodward, Elizabeth Brown, Zoran Popmihajlov, Patricia Saddier, Paula W. Annunziato, Neal A. Halsey, Anne A. Gershon,